Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teh-Ia Huo

Showing results (31-40 of 229) with videos related to

Pageof 23
Sort By:
Transplantation|December 20, 2007
Is the corrected-creatinine model for end-stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation?Samantha C Huo, Teh-Ia Huo, Han-Chieh Lin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 29, 2012
α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinomaYun-Hsuan Lee, Chia-Yang Hsu, Yi-Hsiang Huang, et al.
Cells|July 2, 2021
Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver InjuryYun-Cheng Hsieh, Kuei-Chuan Lee, Pei-Shan Wu, et al.
Regenerative Therapy|September 10, 2024
Harnessing the potential of mesenchymal stem cells-derived exosomes in degenerative diseasesHsiu-Jung Liao, Yi-Ping Yang, Yu-Hao Liu, et al.
Toxicology|December 31, 2002
Molecular pathogenesis of human hepatocellular carcinomaXin W Wang, S Perwez Hussain, Teh-Ia Huo, et al.
The American Journal of Gastroenterology|October 24, 2003
Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal studyTeh-Ia Huo, Wing-Yu Lui, Yi-Hsiang Huang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosisTeh-Ia Huo, Han-Chieh Lin, Jaw-Ching Wu, et al.
The American Journal of Gastroenterology|August 17, 2004
Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatmentTeh-Ia Huo, Jaw-Ching Wu, Wing-Yiu Lui, et al.
Annals of Surgical Oncology|February 7, 2014
Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysisPo-Hong Liu, Yun-Hsuan Lee, Cheng-Yuan Hsia, et al.
Cancers|April 13, 2023
Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Pageof 23

Showing results (31-40 of 229) with videos related to

Sort By:
Pageof 23
Transplantation|December 20, 2007
Is the corrected-creatinine model for end-stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation?Samantha C Huo, Teh-Ia Huo, Han-Chieh Lin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 29, 2012
α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinomaYun-Hsuan Lee, Chia-Yang Hsu, Yi-Hsiang Huang, et al.
Cells|July 2, 2021
Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver InjuryYun-Cheng Hsieh, Kuei-Chuan Lee, Pei-Shan Wu, et al.
Regenerative Therapy|September 10, 2024
Harnessing the potential of mesenchymal stem cells-derived exosomes in degenerative diseasesHsiu-Jung Liao, Yi-Ping Yang, Yu-Hao Liu, et al.
Toxicology|December 31, 2002
Molecular pathogenesis of human hepatocellular carcinomaXin W Wang, S Perwez Hussain, Teh-Ia Huo, et al.
The American Journal of Gastroenterology|October 24, 2003
Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal studyTeh-Ia Huo, Wing-Yu Lui, Yi-Hsiang Huang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosisTeh-Ia Huo, Han-Chieh Lin, Jaw-Ching Wu, et al.
The American Journal of Gastroenterology|August 17, 2004
Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatmentTeh-Ia Huo, Jaw-Ching Wu, Wing-Yiu Lui, et al.
Annals of Surgical Oncology|February 7, 2014
Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysisPo-Hong Liu, Yun-Hsuan Lee, Cheng-Yuan Hsia, et al.
Cancers|April 13, 2023
Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Pageof 23